NAPROXEN

Product NDC
70934-124
11-digit product format
709340124
Labeler code
70934
Product ID
70934-124_b7ae9583-b5b4-97e3-e053-2a95a90a701d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
NAPROXEN
Dosage form
TABLET
Route
ORAL
Labeler
Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application
ANDA091416
Marketing category
ANDA
Marketing start
2018-06-06
Marketing end
0000-00-00
Substance
NAPROXEN
Active strength
500 mg/1
Pharmacologic classes
Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70934-124-207093401242020 TABLET in 1 BOTTLE, PLASTIC (70934-124-20) 20 tablet2019-03-060000-00-00NoNoCurrent
70934-124-307093401243030 TABLET in 1 BOTTLE, PLASTIC (70934-124-30) 30 tablet2018-06-060000-00-00NoNoCurrent
70934-124-607093401246060 TABLET in 1 BOTTLE, PLASTIC (70934-124-60) 60 tablet2019-03-120000-00-00NoNoCurrent
70934-124-907093401249090 TABLET in 1 BOTTLE, PLASTIC (70934-124-90) 90 tablet2019-02-050000-00-00NoNoCurrent